RA-UIP has a poor prognosis, and how to reverse or stabilize the lesions
remains challenging. Based on researches finding that tofacitinib and
IGU might be effective in pulmonary fibrosis, we present 3 cases that
treated with the combined strategy with significant improvement of
DAS28-CRP score and reversals in HRCT.